Abstract
The objective of the present work was to obtain chemopreventive compounds that can trap direct-acting carcinogens within the lumen of the gastrointestinal tract and thus prevent these carcinogens from attacking tissues of the host. Many direct-acting carcinogens are electrophiles (19, 36). One possible strategy for blocking their action is by trapping them with nucleophiles (electron donors). In the studies to be presented, emphasis has been placed on trapping direct-acting carcinogens in two sites, i.e., the stomach and the large intestine. To some extent different considerations pertain for each.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
B. Ames, The detection of environmental mutagens and potential carcinogens. In “Accomplishments in Cancer Research — 1983 Prize Year — General Motors Cancer Res. Found.” (J. G. Fortner and J. E. Rhoads, Eds.), pp. 102–114. J. P. Lippineott, Philadelphia, 1983.
B. N. Ames, J. McCann and E. Yamasaki, Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicitytest. Mutat. Res.,31, 347–364 (1975).
J. M. Anderson, The kinetics of the specific antagonism in vivo of intraarterial methyl-bis(3-chloroethyl)amine hydrochloride by intravenous solutions of hydrous sodium thiosulfate. Cancer, 16, 1281–1287 (1983).
L. F. Bjeldanes and H. Chow, Mutagenicity of 1,2-dicarbonyl compounds: maltol, kojic acid, diacetyl and related substances. Mutat. Res., 67, 367–371 (1979).
G. Bonadonna and D. Karnofsky, Protection studies with sodium thiosulfate against methyl-bis(beta-chloroethyl)amine hydrochloride and its ethylenimonium derivative. Clin. Pharmacol. Ther., 6, 50–64 (1965).
R. K. Boutwell, N. H. Colburn and C. C. Muckerman, In vivo reactions of β-propiolactone. Ann. N. Y. Acad. Sci., 163, 751–764 (1969).
W. R. Bruce, J. Batista, T. Che, R. Furrer, J. S. Ginerich, I. Grupta and J. J. Krepinsky, General structure of “fecapentaenes” — The mutagenic substances in human feces. Naturwissenschaften, 69, 557–558 (1982).
S. Callaway and K. W. Pearce, Protection against systemic poisoning by mustard gas, di(2-chloroethyl) sulphide, by sodium thiosulfate and thiocit in the albino rat. Br. J. Pharmacol., 13, 395–398 (1958).
K. K. Chen and C. L. Rose, Treatment of acute cyanide poisoning. J. Am. Med. Assoc., 162, 1154–1155 (1956).
T. A. Connors, A. Jeney and M. Jones, Reduction of the toxicity of “radiomlmetic” alkylating agents in rats by thiol pretreatment — III. The mechanism of the protective action of thiosulfate. Biochem. Pharmacol., 13, 1545–1550 (1964).
D. L. Dennis and W. S. Fletcher, Toxicity of sodium thiosulfate (NSC-45624), a nitrogen mustard antagonist, in the dog. Cancer Chemother. Rep., 50, 225–257 (1966).
T. L. Gresham, J. E. Jensen, F. W. Shaver and J. T. Gregory, β-propiolactone. II. Reactions with salts of inorganic acids. M, Chem. Soc., 70, 999–1001 (1948).
I. Hatiboglu, E. Mihich, G. E. Moore and C. A. Nichol, Use of sodium thiosulfate as a neutralizing agent during regional administration of nitrogen mustard: an experimental study. Ann. Surg., 156, 994–1001 (1962).
N. Hirai, D. G. I. Kingston, R. L. van Tassell and T. D. Wilkens, Isolation and structure elucidation of fecapentaenes-12, potent mutagens from human feces. Nat. Prod., 48, 622–630 (1985).
— S. B. Howell, C. E. Pfeifle, W. E. Wung and R. A. Olshen, Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res., 43, 1426–1431 (1983).
Y. Iwamoto, T. Kawano, J. Uozumi, K. Aoki and T. Babo, “Two-route chemotherapy” using high dose i.p. cisplatin and i.v. sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice. Cancer Treat. Rep., 68, 1367–1373 (1984).
W. G. Jaffe, The influence of sodium thiosulfate on experimental tumor induction. Experientia, IV, 234–236 (1948).
A. H. James and G. W. Pickering, The role of gastric acidity in the pathogenesis of peptic ulcer. Clin. Sci., 8, 181–210 (1949).
P. D. Lawley, Carcinogenesis by alkylating agents. In: Chemical Carcinogens, ACS Monograph 173, pp. 83–244. Am. Chem. Soc., Washington, DC, 1976.
D. M. Maron and B. N. Ames, Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173–215 (1983).
J. McCann, E. Choi, E. Yamasaki and B. Ames, Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci., USA, 72, 5135–5139 (1975).
H. Marquardt, M. D. Sapozink and M. S. Zedeck, Inhibition of cysteamine-HCl on oncogenesis induced by 7,12-dimethylbenz(a)anthracene without affecting toxicity. Cancer Res., 34, 3387–3390 (1974).
C. N. Myers, M. R. Groehl and C. P. Metz, Therapeutic activity of sodium thiosulfate. Proc. Soc. Exp. Biol. Med., 23, 97–101 (1925).
G. Owens and I. Hatibozlu, Clinical evaluation of sodium thiosulfate as a systemic neutralizer of nitrogen mustard. Ann. Surg., 154, 895–897 (1961).
U. D. G. Prabhu and L. W. Wattenberg. Synthesis of α1,α3,α5 -tris-(4’-mercaptophenoxy)mellitene (unpublished).
D. Schmahl, M. Habs and A. M. Tacchi, Prophylaxe der Tumorentstehung in der Harnblase durch Natrium-2-mercaptoethansulfonat (Mesma). Urologie, 291–296 (1984).
A. Segal, J. J. Solomon, J. Mignano and J. Dino. The isolation and characterization of 3-(2-carboxyethyl)cytosine following in vitro reaction of 3-propiolactone with calf thymus DNA. Chem. Biol. Interact., 35, 349–361 (1981).
M. Shed, J. A. Koziol and S. B. Howell, Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin. Pharmacol. Ther. 35, 419–425 (1984).
C. G. Swain and C. B. Scott, Quantitative correlation of relative rates. Comparison of hydroxide ion with other nucleophilic reagents toward allyl halides, esters, epoxides and acyl halides. M, Chem. Soc., 75, 141–147 (1953).
J. Uozumi, M. Ishizawa, Y. Iwamoto and T. Bab, Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity. Cancer Chemother. Pharmacol., 13, 82–85 (1984).
B. L. Van Duuren, Carcinogenic epoxides, lactones, and halo ethers and their mode of action. Ann. N. Y. Acad. Sci., 163, 633–651 (1969).
L. W. Wattenberg, Chemoprevention of cancer. Cancer Res., 45, 1–8 (1985).
L. W. Wattenberg, P. Borchert, C. M. Destafney and J. B. Coccia, Effects of p-methoxyphenol and diet on carcinogen-induced neoplasia of the mouse forestomach. Cancer Res., 43, 4747–4751 (1983).
L. W. Wattenberg, J. B. Hochalter and A. R. Galbraith, Inhibition of beta-propiolactone-induced neoplasia by sodium thiosulfate. Cancer Res. (submitted 1987).
L. W. Wattenberg, U. D. G. Prabhu, J. B. Hochalter and A. R. Galbraith, Inhibitory effects of 4-mercaptobenzene sulfonate and α1,α3,α5-tris-4’mercaptophenoxy)mellitene on direct-acting carcinogens. Proc. Am. Assoc. Cancer Res., 27, 1987 (in press).
J. H. Weisburger and G. M. Williams, Metabolism of chemical carcinogens. In: Cancer: A Comprehensive Treatise (F. F. Becker, Ed.), Vol. 1 (2nd ed.), pp. 241–331. Plenum, New York, 1982.
J. Westley, Rhodanese and the sulfane pool. In: Enzymatic Basis of Detoxification, (W. B. Jakoby, Ed.), Vol. II, pp. 245–262. Academic Press, New York, 1980.
E. Wickstrom, Chlorambucil inhibition by dimethyl sulfoxide and thiosulfate: implications for chlorambucil chemotherapy. Med. Hypotheses, 6, 1035–1041 (1980).
C. E. Williamson, A. M. Seligman and B. Witten, Intracellular toxic reactions of some sulfur and nitrogen mustards. Pharmacol. Exp. Ther., 182, 77–82 (1942).
A. W. Wright, R. S. Crowne and D. E. Hathway, The fate of 2,4,6-tri-(3’,5’-di-tert-butyl-4’-hydroxybenzyl)mesitylene (lonex 330) in the dog and rat. Biochem. J., 95, 98–103 (1965).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Wattenberg, L.W., Hochalter, J.B., Prabhu, U.D.G., Galbraith, A.R. (1987). Nucleophiles as Anticarcinogens. In: Cerutti, P.A., Nygaard, O.F., Simic, M.G. (eds) Anticarcinogenesis and Radiation Protection. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6462-1_36
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6462-1_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6464-5
Online ISBN: 978-1-4615-6462-1
eBook Packages: Springer Book Archive